Serum RNase in the diagnosis of pancreatic carcinoma.
Serum RNase (RNase I; ribonuclease 3'-pyrimidino-oligonucleotidohydrolase, EC 3.1.4.22) activity (mean +/- SD) with polycytidine as substrate was determined in normal individuals (24.9 +/- 3.0 units/ml) and in patients with pancreatic cancer (37.3 +/- 14.8), pancreatitis (38.5 +/- 12.6), nonpancreat...
Tallennettuna:
| Julkaisussa: | Proc Natl Acad Sci U S A |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
National Academy of Sciences
1979
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC383661/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/288051/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.76.6.2630 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|